Companies › VSTM

VERASTEM INC (VSTM)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001526119 · EDGAR filings · Updated 2026-07-23

VERASTEM INC (VSTM) has reported institutional ownership of 92.7%, with 155 institutional managers holding positions valued at $431.5M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-23 — Notice of proposed sale filed (Form 144)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-08 — SCHEDULE 13G/A filed
• 2026-06-25 — Notice of proposed sale filed (Form 144)
• 2026-06-24 — Insider transaction reported (Form 4)
• 2026-06-24 — Insider transaction reported (Form 4)
• 2026-06-23 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, VERASTEM INC has 155 institutional holders and institutional ownership of 92.7%.

Insider activity

Insiders reported 58 transactions (0 buys, 41 sells) across 12 reporting insiders, with a net reported value of −$1.38M.

Data flags from SEC filings

Related companies

ANGIODYNAMICS INC (ANGO) · ABCELLERA BIOLOGICS INC (ABCL) · DBV TECHNOLOGIES S A (DBVT) · RIGEL PHARMACEUTICALS INC (RIGL) · TECTONIC THERAPEUTIC INC (TECX) · ACLARIS THERAPEUTICS (ACRS)